Darrell J. Triulzi, MD
Dr. Triulzi is the Director of the Division of Transfusion Medicine, Department of Pathology and Medical Director, Institute for Transfusion Medicine. Dr Triulzi serves as the division leader in transfusion medicine. The division provides clinical transfusion support to the UPMC health system hospitals and is actively involved in its Patient Blood Management Program. Dr Triulzi leads a robust clinical research program in the division.
Professor of Pathology
Institute for Transfusion Medicine
3636 Blvd. of the Allies
Pittsburgh, PA 15213
Office Telephone: 412-209-7304
- MD - Albany Medical College, 1985
Clinical ExpertiesDr. Triulzi has general expertise in the area of transfusion medicine with particular clinical and research expertise in transfusion support of organ and stem cell transplant patients. He is highly involved both locally and nationally in Patient Blood Management and its application to orthopedic surgery, cardiac surgery and trauma.
Research InterestsDr Triulzi has held numerous grants in the area of transfusion medicine and currently serves as PI on the NIH REDSIII grant. His interests include adverse effects of transfusion, platelet transfusions, the red cells storage lesion and epidemiologic studies of transfusion.
Selected PublicationsView Dr. Triulzi's publications on PubMed
Berg A, Courtney R, Krishnamurti L, Triulzi DJ, Yazer MH. Is intensive monitoring during the first transfusion in pediatric patients necessary? Hematology 2014 Jul;19(5):304-8
Yazer MH, Triulzi DJ, Reddy V, Waters JH. Effectiveness of a real-time clinical decision support system for computerized physician order entry of plasma orders. Transfusion. 2013;53:3120-7.
Collins RA, Triulzi DJ, Waters JH, Reddy V, Yazer MH. Evaluation of Real-Time Clinical Decision Support Systems for Platelet and Cryoprecipitate Orders. Am J Clin Pathol 2014; 141(1):78-84.
Harm SK, Yazer MH, Monis GF, Triulzi DJ, Aubuchon JP, Delaney M. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Am J Clin Pathol. 2014 Feb;141(2):256-61.
McWilliams B, Triulzi DJ, Waters JH, Alarcon LH, Reddy V, Yazer MH. Trends in RBC ordering and use after implementing adaptive alerts in the electronic computerized physician order entry system. Am J Clin Pathol. 2014 Apr;141(4):534-41
Roubinian NH, Escobar GJ,Liu V,Swain BE,Gardner MN,Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL. Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion, 2014:online Aug
Yazer MH, Triulzi DJ. Things aren't always as they seem: what the randomized trials of red blood cell transfusion tell us about adverse outcomes. Transfusion 2014;54:3243-6.
Collins RA, Wisniewski MK, Waters JH, Triulzi D, Yazer MH. Effectiveness of multiple initiatives to reduce blood component wastage. Am J Clin Pathol 2015; 143(1):329-335.
Kaufman RM, Assman S, Triulzi DJ, et al. Transfusion related adverse events in the Platelet Dose Study. Transfusion 2015;55:144-53.
Dilla A, Wisniewski MK, Waters JH, Triulzi DJ, Yazer MH. Hematology 2015;20:160-4.
Triulzi DJ, Gottschall J, Murphy E, etal. A multicenter study of plasma use in the US. Transfusion 2015;55:1313-9.